跳转至内容
Merck
CN

63081

氢氧化镁

BioUltra, ≥99.0% (KT)

别名:

Magnesium dihydroxide, Mg(OH)2

登录 查看组织和合同定价。

选择尺寸


关于此项目

线性分子式:
Mg(OH)2
化学文摘社编号:
分子量:
58.32
NACRES:
NA.25
PubChem Substance ID:
UNSPSC Code:
12352303
EC Number:
215-170-3
MDL number:
Assay:
≥99.0% (KT)
Grade:
reagent grade
Solubility:
5 M HCl: 0.1 M at 20 °C, clear, colorless
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI key

VTHJTEIRLNZDEV-UHFFFAOYSA-L

InChI

1S/Mg.2H2O/h;2*1H2/q+2;;/p-2

SMILES string

O[Mg]O

grade

reagent grade

product line

BioUltra

assay

≥99.0% (KT)

impurities

Insoluble matter, passes filter test

mp

350 °C (lit.)

solubility

5 M HCl: 0.1 M at 20 °C, clear, colorless

anion traces

chloride (Cl-): ≤500 mg/kg, sulfate (SO42-): ≤1000 mg/kg

cation traces

As: ≤0.1 mg/kg, Ba: ≤10 mg/kg, Bi: ≤50 mg/kg, Ca: ≤5000 mg/kg, Cd: ≤5 mg/kg, Co: ≤5 mg/kg, Cr: ≤5 mg/kg, Cu: ≤5 mg/kg, Fe: ≤100 mg/kg, K: ≤50 mg/kg, Li: ≤5 mg/kg, Mn: ≤10 mg/kg, Mo: ≤5 mg/kg, Na: ≤100 mg/kg, Ni: ≤100 mg/kg, Pb: ≤5 mg/kg, Sr: ≤10 mg/kg, Zn: ≤5 mg/kg

λ

0.1 M in 5 M HCl

UV absorption

λ: 260 nm Amax: 0.030, λ: 280 nm Amax: 0.025

Quality Level

正在寻找类似产品? 访问 产品对比指南

General description

Magnesium hydroxide is commonly used as a non-systemic antacid for treating acid-peptic disorders. It helps in the treatment kidney stones patients by reducing the recurrence rate.

Application

Magnesium hydroxide is used as a dietary supplement to study its effects on the absorbtion of factors such as folic acid and iron and the release of the peptide hormone cholecystokinin (CCK).

存储类别

13 - Non Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

B K Snyder et al.
Annals of emergency medicine, 33(4), 400-405 (1999-03-27)
Animal models have demonstrated that administration of magnesium hydroxide (MgOH) decreases serum iron levels after an iron overdose. We designed this study to determine the effect of MgOH administration on iron absorption and adverse effects after a supratherapeutic dose of
R M Russell et al.
The Journal of laboratory and clinical medicine, 112(4), 458-463 (1988-10-01)
Intestinal folic acid transport is a saturable process with a pH optimum of 5.5 to 6.0. Because of the possible effects of antacids and acid-lowering drugs on the pH of the proximal small intestine, the influence of these drugs on
G Johansson et al.
The Journal of urology, 124(6), 770-774 (1980-12-01)
Prophylactic treatment with magnesium hydroxide ws instituted in 56 consecutive cases with renal calcium stones. The patients had been investigated previously with regard to the magnesium metabolism. The urinary magnesium excretion increased promptly and remained on a higher level during
Tomohito Kameda et al.
Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering, 48(1), 86-91 (2012-10-04)
A selective catalytic reduction process is generally used to treat NO(x); however, this approach results in the leakage of ammonia and requires expensive catalysts. In light of these issues, the specific objective of this study was to develop a new
Mitsuru Koike et al.
ChemSusChem, 5(12), 2312-2314 (2012-11-09)
Doing fine with Ni-Fe: The calcination and reduction of a hydrotalcite precursor containing Ni and Fe ions gives uniform Ni-Fe alloy nanoparticles mixed with Mg(Ni, Fe, Al)O particles. The uniformity of the Ni-Fe alloy nanoparticles is connected to the catalyst's high activity

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持